Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Balasubbu, Suganthalakshmi ^a,b   Sundaresan, Periasamy ^a   Rajendran, Anand ^c   Ramasamy, Kim ^c   Govindarajan, Gowthaman ^a   Perumalsamy, Namperumalsamy ^c   Hejtmancik, J Fielding ^b  

^a ARAVIND MEDICAL RESEARCH FOUNDATION   (India)

^b NATIONAL EYE INSTITUTE   (United States)

^c ARAVIND EYE HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AGE RELATED MACULOPATHY SUSCEPTIBILITY 2 PROTEIN; ALDEHYDE REDUCTASE; BIOLOGICAL MARKER; COMPLEMENT FACTOR H; ERYTHROPOIETIN; HEMOJUVELIN; HFE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; ORAL ANTIDIABETIC AGENT; PEPTIDASE; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN; PROTEIN HTRA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DINUCLEOTIDE REPEAT; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD PRESSURE; CHROMOSOME MAP; DOMINANT GENE; GENETICS; INDIA; MIDDLE AGED; ONSET AGE; PATHOPHYSIOLOGY; RISK;

ADULT; AGE OF ONSET; BLOOD PRESSURE; CHROMOSOME MAPPING; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENES, DOMINANT; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78149267892     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-158     Document Type: Article

References (41)

1. Resnikoff S. Global data on visual impairment in the year 2002. Bulletin of the World Health Organization 2004, 82:844-851. 2623053, 15640920.
2. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984, 102:527-532.
3. Patz A. Studies on retinal neovascularization. Friedenwald Lecture. Invest Ophthalmol Vis Sci 1980, 19:1133-1138.
4. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996, 45:1289-1298. 10.2337/diabetes.45.10.1289, 8826962.
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:837-853. 10.1016/S0140-6736(98)07019-6, 9742976.
6. Sulochana KN, Ramakrishnan S, Rajesh M, Coral K, Badrinath SS. Diabetic retinopathy: Molecular mechanisms, present regime of treatment and future prospectives. Current Science 2001, 80:133-142.
7. Fong DS, Aiello LP, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care 2004, 27:2540-2553. 10.2337/diacare.27.10.2540, 15451934.
8. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC, . Pima Diabetes Genes Group Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 1998, 47:821-830. 10.2337/diabetes.47.5.821, 9588456, Pima Diabetes Genes Group.
9. Looker HC, Nelson RG, Chew E, Klein R, Klein BE, Knowler WC, Hanson RL. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes 2007, 56:1160-1166. 10.2337/db06-1299, 17395753.
10. Hallman DM, Boerwinkle E, Gonzalez VH, Klein BE, Klein R, Hanis CL. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas. Diabetes 2007, 56:1167-1173. 10.2337/db06-1373, 17251272.
11. Petrovic MG, Peterlin B, Hawlina M, Petrovic D. Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians. J Diabetes Complications 2005, 19:70-73. 10.1016/j.jdiacomp.2004.08.004, 15745835.
12. Hudson BI, Stickland MH, Grant PJ. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 1998, 47:1155-1157. 10.2337/diabetes.47.7.1155, 9648842.
13. Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P, Sundaresan P. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 2006, 12:336-341.
14. Liu L, Yu Q, Wang H, Zhang SX, Huang C, Chen X. Association of intercellular adhesion molecule 1 polymorphisms with retinopathy in Chinese patients with Type 2 diabetes. Diabet Med 2006, 23:643-648. 10.1111/j.1464-5491.2006.01884.x, 16759306.
15. Iizuka H, Awata T, Osaki M, Neda T, Kurihara S, Inoue K, Inukai K, Kabasawa S, Mori K, Yoneya S, Katayama S. Promoter polymorphisms of the pigment epithelium-derived factor gene are associated with diabetic retinopathy. Biochem Biophys Res Commun 2007, 361:421-426. 10.1016/j.bbrc.2007.07.025, 17658465.
16. Peterlin B, Globocnik PM, Makuc J, Hawlina M, Petrovic D. A hemochromatosis-causing mutation C282Y is a risk factor for proliferative diabetic retinopathy in Caucasians with type 2 diabetes. J Hum Genet 2003, 48:646-649. 10.1007/s10038-003-0094-3, 14618419.
17. Matsubara Y, Murata M, Maruyama T, Handa M, Yamagata N, Watanabe G, Saruta T, Ikeda Y. Association between diabetic retinopathy and genetic variations in alpha2beta1 integrin, a platelet receptor for collagen. Blood 2000, 95:1560-1564.
18. Uthra S, Raman R, Mukesh BN, Padmaja Kumari R, Paul PG, Lakshmipathy P, Gnanamoorthy P, Sharma T, McCarty CA, Kumaramanickavel G. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India. Ophthalmic Genet 2007, 28:77-81. 10.1080/13816810701209669, 17558849.
19. Uthra S, Raman R, Mukesh BN, Rajkumar SA, Kumari RP, Agarwal S, Paul PG, Lakshmipathy P, Gnanamoorthy P, Sharma T, McCarty CA, Kumaramanickavel G. Diabetic retinopathy and IGF-1 gene polymorphic cytosine-adenine repeats in a Southern Indian cohort. Ophthalmic Res 2007, 39:294-299. 10.1159/000108124, 17851271.
20. Liu L, Xiang K. RAGE Gly82Ser polymorphism in diabetic microangiopathy. Diabetes Care 1999, 22:646. 10.2337/diacare.22.4.646, 10189547.
21. Kumaramanickavel G, Ramprasad VL, Sripriya S, Upadyay NK, Paul PG, Sharma T. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J Diabetes Complications 2002, 16:391-394. 10.1016/S1056-8727(02)00187-3, 12477623.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215. 10.1093/nar/16.3.1215, 334765, 3344216.
23. Kumaramanickavel G, Sripriya S, Ramprasad VL, Upadyay NK, Paul PG, Sharma T. Z-2 aldose reductase allele and diabetic retinopathy in India. Ophthalmic Genet 2003, 24:41-48. 10.1076/opge.24.1.41.13889, 12660865.
24. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988, 318:1315-1321. 10.1056/NEJM198805193182007, 3283558.
25. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999, 84:489-497.
26. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994, 70:138-151.
27. Yoshioka K, Yoshida T, Takakura Y, Umekawa T, Kogure A, Toda H, Yoshikawa T. Relation between polymorphisms G1704T and G82S of rage gene and diabetic retinopathy in Japanese type 2 diabetic patients. Intern Med 2005, 44:417-421. 10.2169/internalmedicine.44.417, 15942086.
28. Zhang HM, Chen LL, Wang L, Liao YF, Wu ZH, Ye F, Xu S, Yi LL. Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population. J Endocrinol Invest 2009, 32:258-262.
29. Srinivasan SR, Li S, Chen W, Tang R, Bond MG, Boerwinkle E, Berenson GS. Q192R polymorphism of the paraoxanase 1 gene and its association with serum lipoprotein variables and carotid artery intima-media thickness in young adults from a biracial community. The Bogalusa Heart Study. Atherosclerosis 2004, 177:167-174.
30. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007, 80:531-538. 10.1086/512133, 1821115, 17273975.
31. Mori K, Imai K, Matsuda A, Ikeda Y, Naruse S, Hitora-Takeshita H, Nakano M, Taniguchi T, Omi N, Tashiro K, Kinoshita S. LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population. Mol Vis 2008, 14:1037-1040. 2426718, 18552979.
32. Fuse N, Miyazawa A, Nakazawa T, Mengkegale M, Otomo T, Nishida K. Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese. Mol Vis 2008, 14:1338-1343. 2480481, 18648524.
33. Brahmachari SK, Majumder PP, Mukerji M, Habib S, Dash D, Ray K, et al. Indian Genome Variation Consortium: Genetic landscape of the people of India: a canvas for disease gene exploration. J Genet 2008, 87:3-20. 10.1007/s12041-008-0002-x, 18560169.
34. Hudson BI, Stickland MH, Futers TS, Grant PJ. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001, 50:1505-1511. 10.2337/diabetes.50.6.1505, 11375354.
35. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, Tam PO, Chan WM, Lam DS, Snyder M, Barnstable C, Pang CP, Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006, 314:989-992. 10.1126/science.1133807, 17053108.
36. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006, 314:992-993. 10.1126/science.1133811, 17053109.
37. Gibbs D, Yang Z, Constantine R, Ma X, Camp NJ, Yang X, Chen H, Jorgenson A, Hau V, Dewan A, Zeng J, Harmon J, Buehler J, Brand JM, Hoh J, Cameron DJ, Dixit M, Tong Z, Zhang K. Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration. Vision Res 2008, 48:685-689. 10.1016/j.visres.2007.10.022, 18207215.
38. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389. 10.1126/science.1109557, 1512523, 15761122.
39. Chen LJ, Liu DT, Tam PO, Chan WM, Liu K, Chong KK, Lam DS, Pang CP. Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis 2006, 12:1536-1542.
40. Kondo N, Honda S, Ishibashi K, Tsukahara Y, Negi A. LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 2007, 144:608-612. 10.1016/j.ajo.2007.06.003, 17692272.
41. Tong Z, Yang Z, Patel S, et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci USA 2008, 105:6998-7003. 10.1073/pnas.0800454105, 2383970, 18458324.